End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-01FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution, from Vantive US Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients [NA]
A terminated clinical trial evaluated delivering soluble ferric pyrophosphate via the dialysate to maintain iron balance in patients with en…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD [Phase 2]
A Phase 2A trial evaluating FMX-8 for anemia in patients with end-stage renal disease on hemodialysis was terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation [Phase 1, Phase 2]
Clinical trial update reporting safety data for tocilizumab aimed at increasing transplant rates in highly sensitized patients with end-stag…
-
FDA approval · 2015-07-29FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution from Vantive US Healthcare LLC…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study [NA]
A randomized trial tests whether adjusting fluid removal during hemodialysis using blood volume measurements reduces intradialytic hypotensi…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D [Phase 3]
Phase 3 randomized open-label trial comparing maintenance IV Monofer (iron isomaltose) given as single or repeated bolus injections with IV …
-
CLINICAL_TRIALS withdrawal · 2015-07-17Clinical Trial Update: An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis. [Phase 2]
Phase 2 trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of 12 weeks of Simeprevir plus Daclatasvir in chronic hepa…
-
CLINICAL_TRIALS research · 2015-07-13Clinical Trial Update: Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis [NA]
This clinical trial update describes efforts to increase removal of protein-bound solutes during extended-hours hemodialysis in patients wit…
-
CLINICAL_TRIALS research · 2015-07-08Clinical Trial Update: Induction With SVF Derived MSC in Living-related Kidney Transplantation [Phase 1, Phase 2]
This entry reports a Phase 1/Phase 2 clinical trial evaluating induction with SVF-derived mesenchymal stem cells in living-related kidney tr…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer
This completed clinical trial investigates cancer incidence and survival after kidney transplantation, comparing recipients with pre-transpl…
-
CLINICAL_TRIALS research · 2015-07-08Clinical Trial Update: Effect of SVF Derived MSC in DCD Renal Transplantation [Phase 1, Phase 2]
This update covers Phase 1 and Phase 2 investigations of stromal vascular fraction–derived mesenchymal stem cells in donation-after-circulat…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: The Study of Association Between Intradialysis Sodium Balance and Clinical Outcomes in Chronic Hemodialysis Patients
This clinical trial update examines the association between intradialysis sodium balance and clinical outcomes in patients with end-stage re…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation [Phase 4]
Phase 4 trial evaluating strategies to reduce panel reactive antibodies in sensitized patients awaiting kidney transplantation. The study ha…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET) [Phase 2]
Phase 2 clinical trial targeting two phosphate targets in end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating eculizumab to prevent antibody-mediated rejection in ABO-incompatible living-donor kidney transplantatio…
-
FDA approval · 2015-06-09FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride (Renagel) submitted by Sanofi-Aventis U.S. LLC. The approval updates the…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Safety and Dialysability of Dotarem® in Dialysed Patients [Phase 1]
This Phase 1 study assessed the safety and dialysability of the MRI contrast agent Dotarem (gadoterate meglumine) in patients with end-stage…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: DIVINE: Dialysis Infection and Vitamin D In New England [NA]
The DIVINE trial evaluating dialysis infection and vitamin D in end-stage renal disease has completed, with results posted in 2015.
-
FDA approval · 2015-06-05FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for DIANEAL PD-2 WITH DEXTROSE, a peritoneal dialysis solution, under Vantive US Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism [Phase 4]
Phase 4 randomized multicenter cross-over trial comparing Physioneal 35 to 40 on protein metabolism in patients with end-stage renal disease…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients [Phase 4]
Phase 4 clinical trial comparing platelet resistance with ticagrelor versus standard-dose clopidogrel in patients with Acute Coronary Syndro…
-
CLINICAL_TRIALS research · 2015-06-01Clinical Trial Update: Predictors and Intervention for Noncompliance [NA]
This update reports on a completed clinical trial examining predictors of noncompliance and possible intervention strategies in kidney trans…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Effect of Varied Dialysate Bicarbonate Levels on Phosphate and Potassium Removal [Phase 4]
Phase 4 clinical trial update evaluating the effect of varied dialysate bicarbonate levels on phosphate and potassium removal in chronic dia…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Pomegranate and Hemodialysis Pilot Trial [NA]
This ClinicalTrials.gov update indicates the completed status of a pilot trial evaluating pomegranate supplementation in patients with end-s…